2026-04-17T01:56:13Zhttps://recercat.cat/oai/request

oai:recercat.cat:11351/81192025-12-20T16:16:44Zcom_2072_378070com_2072_378040col_2072_378092

urn:hdl:11351/8119 Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia Casado, Jose A Valeri, Antonio Sánchez-Domínguez, Rebeca López, Andrea Navarro, Susana Díaz de Heredia Rubio, Maria Cristina Vela Cristobal, Paula Anèmia de Fanconi Cèl·lules mare hematopoètiques Regulació genètica DISEASES::Hemic and Lymphatic Diseases::Hematologic Diseases::Anemia::Anemia, Aplastic::Anemia, Hypoplastic, Congenital::Fanconi Anemia ANATOMY::Cells::Bone Marrow Cells::Hematopoietic Stem Cells PHENOMENA AND PROCESSES::Genetic Phenomena::Gene Expression Regulation::Up-Regulation ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades hematológicas::anemia::anemia aplásica::anemia hipoplásica congénita::anemia de Fanconi ANATOMÍA::células::células de la médula ósea::células madre hematopoyéticas FENÓMENOS Y PROCESOS::fenómenos genéticos::regulación de la expresión génica::regulación positiva Cellular immune response; Immunology; Stem cells Respuesta inmune celular; Inmunología; Células madre Resposta immune cel·lular; Immunologia; Cèl·lules mare Fanconi anemia (FA) is the most prevalent inherited bone marrow failure (BMF) syndrome. Nevertheless, the pathophysiological mechanisms of BMF in FA have not been fully elucidated. Since FA cells are defective in DNA repair, we hypothesized that FA hematopoietic stem and progenitor cells (HSPCs) might express DNA damage–associated stress molecules such as natural killer group 2 member D ligands (NKG2D-Ls). These ligands could then interact with the activating NKG2D receptor expressed in cytotoxic NK or CD8+ T cells, which may result in progressive HSPC depletion. Our results indeed demonstrated upregulated levels of NKG2D-Ls in cultured FA fibroblasts and T cells, and these levels were further exacerbated by mitomycin C or formaldehyde. Notably, a high proportion of BM CD34+ HSPCs from patients with FA also expressed increased levels of NKG2D-Ls, which correlated inversely with the percentage of CD34+ cells in BM. Remarkably, the reduced clonogenic potential characteristic of FA HSPCs was improved by blocking NKG2D–NKG2D-L interactions. Moreover, the in vivo blockage of these interactions in a BMF FA mouse model ameliorated the anemia in these animals. Our study demonstrates the involvement of NKG2D–NKG2D-L interactions in FA HSPC functionality, suggesting an unexpected role of the immune system in the progressive BMF that is characteristic of FA. This work was supported by the “Ministerio de Ciencia e Innovación y Competitividad y Fondo Europeo de Desarrollo Regional (FEDER)” (SAF2015-68073-R, SAF2015-64152-R, and RTI2018-097125-B-I00); Next Generation EU; Plan de Recuperación Transformación y Resilencia (Instituto de Salud Carlos III; TERAV) (RD12/0019/0023); Programs of the European Commission (HEALTHF5-2012-305421 and EUROFANCOLEN); the “Ministerio de Sanidad, Servicios Sociales e Igualdad” (EC11/060 and EC11/550 “Comunidad de Madrid” (AvanCell, B2017/BMD-3692); and the ICREA-Academia program. 2022-09-09T12:50:57Z 2022-09-09T12:50:57Z 2022-08-01 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion The Journal of Clinical Investigation;132(15) http://dx.doi.org/10.1172/JCI142842 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess American Society for Clinical Investigation Scientia